1. Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies 
Gunjan L. Shah, Leyla Shune, Duncan Purtill, Sean Devlin, Emily Lauer, Marissa Lubin, Valkal Bhatt, Courtney McElrath, Nancy A. Kernan, Andromachi Scaradavou, Sergio Giralt, Miguel A. Perales, Doris M. Ponce, James W. Young, Monica Shah, Genovefa Papanicolaou, Juliet N. Barker 
Biology of Blood and Marrow Transplantation 
Volume 21, Issue 12, Pages (December 2015)
DOI: /j.bbmt
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Prevnar response for 3 clinically significant pneumococcal serotypes (14, 19F, and 23F) in 58 double-unit CBT recipients. Responses are split by children (n = 15) and adults (n = 43).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Primary series responses for Tdap, HiB, and polio in double-unit CBT recipients who received ≥ 2 vaccines in the primary series by age. Three children received either Pediarix or Infanrix, whereas all other patients received Boostrix.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions